ArticleArXiv2025
Advances in Surrogate Modeling for Biological Agent-Based Simulations: Trends, Challenges, and Future Prospects.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
Agent-based modeling (ABM) is a powerful computational approach for studying complex biological and biomedical systems, yet its widespread use remains limited by significant computational demands. As models become increasingly sophisticated, the number of parameters and interactions rises rapidly, exacerbating the so-called "curse of dimensionality" and making comprehensive parameter exploration and uncertainty analyses computationally prohibitive. Surrogate modeling provides a promising solution by approximating ABM behavior through computationally efficient alternatives, greatly reducing the runtime needed for parameter estimation, sensitivity analysis, and uncertainty quantification. In this review, we examine traditional approaches for performing these tasks directly within ABMs-providing a baseline for comparison-and then synthesize recent developments in surrogate-assisted methodologies for biological and biomedical applications. We cover statistical, mechanistic, and machine-learning-based approaches, emphasizing emerging hybrid strategies that integrate mechanistic insights with machine learning to balance interpretability and scalability. Finally, we discuss current challenges and outline directions for future research, including the development of standardized benchmarks to enhance methodological rigor and facilitate the broad adoption of surrogate-assisted ABMs in biology and medicine.
Indexed as
Identifiers
40321948PMC12047901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.